Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 42 |  Ruemmler Kathryn H.Chief Legal Officer, GC |  GSGOLDMAN SACHS GROUP INCOpen-market sale | SELL | $535K 580 sh |
| Jan 27, 2026 traded Jan 23, 2026 |
| 41 | Freve Maria GSee Remarks | SYMSymbotic Inc. Open-market sale | SELL | $400K 6,667 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 39 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $155K 167 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $71K 76 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Halio CareyGlobal Treasurer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $126K 136 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $81K 87 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Halio CareyGlobal Treasurer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $172K 187 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Halio CareyGlobal Treasurer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $135K 146 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Ruemmler Kathryn H.Chief Legal Officer, GC | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $56K 60 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $133K 144 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Ruemmler Kathryn H.Chief Legal Officer, GC | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $167K 178 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Halio CareyGlobal Treasurer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $241K 262 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $115K 124 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Halio CareyGlobal Treasurer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $233K 252 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 39 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $192K 208 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 36 | Alam KamranCHIEF FINANCIAL OFFICER |  TSHATaysha Gene Therapies, Inc.Open-market sale | SELL | $375K 79.0K sh | Jan 27, 2026 traded Jan 23, 2026 |
| 36 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $37K 40 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 36 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $11K 12 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 36 | Fredman Sheara JChief Accounting Officer | GSGOLDMAN SACHS GROUP INC Open-market sale | SELL | $9,360 10 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 34 | Howe JolandaSVP, GLOBAL CONTROLLER |  MIRMMirum Pharmaceuticals, Inc.Open-market sale | SELL | $81K 842 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 33 | Banks Margaret KatherineDirector |  HALHALLIBURTON COOpen-market sale | SELL | $89K 2,600 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 32 | Nagendran SukumarDirector, President and Head of R&D | TSHATaysha Gene Therapies, Inc. Open-market sale | SELL | $423K 89.1K sh | Jan 27, 2026 traded Jan 23, 2026 |
| 30 | Kuffner JamesCHIEF TECHNOLOGY OFFICER | SYMSymbotic Inc. Open-market sale | SELL | $63K 1,048 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 30 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $718K 2,600 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 25 | Nagendran SukumarDirector, President and Head of R&D | TSHATaysha Gene Therapies, Inc. Open-market sale | SELL | $124K 26.9K sh | Jan 27, 2026 traded Jan 26, 2026 |
| 25 | Alam KamranCHIEF FINANCIAL OFFICER | TSHATaysha Gene Therapies, Inc. Open-market sale | SELL | $110K 23.8K sh | Jan 27, 2026 traded Jan 26, 2026 |
| 24 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $1.56M 51.9K sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $64K 227 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $119K 429 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $144K 524 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $117K 421 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 23 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $74K 263 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $145K 514 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Walsh John FCEO-The Americas | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $3,360 12 sh | Jan 27, 2026 traded Jan 27, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $17K 62 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $283 1 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 20 | Hogan Catherine KiernanChief Operating Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $30K 107 sh | Jan 27, 2026 traded Jan 26, 2026 |
| 18 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $244K 8,135 sh | Jan 27, 2026 traded Jan 23, 2026 |
| 15 | Singh Ritadhwaja JebensEVP & CHIEF DIGITAL OFFICER |  LTHLife Time Group Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $360K 12.1K sh | Jan 27, 2026 traded Jan 23, 2026 |
| 13 | Clifford Katherine LeeChief Leadership & HR Officer | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $20K 71 sh | Jan 27, 2026 traded Jan 26, 2026 |